Kazia Therapeutics KZIA Edges Higher as Biotech Sector Watches Key Levels US Productivity Growth Slows as Labor Costs Accelerate in Fourth Quarter ALNT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Climbs 61 Tax Foundation OpEd Challenges TrumpEra Tariff Policies Citing Economic Weakness